Trials / Completed
CompletedNCT00189735
A Study to Evaluate FK778 in Kidney Transplant Patients
A Multicentre, Randomised, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Different Concentrations of FK778 With Tacrolimus (FK506) and Steroids Versus a Standard Regimen of Tacrolimus, MMF and Steroids in Renal Transplant Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 364 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A dose finding study to evaluate the safety and effectiveness of FK778 in kidney transplant patients
Conditions
- Kidney Transplantation
- Renal Transplantation
- Transplantation, Renal
- Transplantation, Kidney
- Grafting, Kidney
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FK778 |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2005-10-01
- Completion
- 2005-10-01
- First posted
- 2005-09-19
- Last updated
- 2008-04-17
Locations
37 sites across 12 countries: Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, Sweden, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00189735. Inclusion in this directory is not an endorsement.